vs

Side-by-side financial comparison of TWFG, Inc. (TWFG) and Vericel Corp (VCEL). Click either name above to swap in a different company.

Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $70.3M, roughly 1.3× TWFG, Inc.). Vericel Corp runs the higher net margin — 25.0% vs 22.3%, a 2.7% gap on every dollar of revenue. TWFG, Inc. produced more free cash flow last quarter ($53.1M vs $12.8M).

TWFG, Inc. (The Woodlands Financial Group) is a U.S.-headquartered financial services firm specializing in insurance brokerage, wealth management, and financial planning. It mainly serves individual consumers, small business owners, and enterprise clients across North America, delivering tailored risk coverage solutions and personalized advisory support to help clients manage risk and meet their financial objectives.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

TWFG vs VCEL — Head-to-Head

Bigger by revenue
VCEL
VCEL
1.3× larger
VCEL
$92.9M
$70.3M
TWFG
Higher net margin
VCEL
VCEL
2.7% more per $
VCEL
25.0%
22.3%
TWFG
More free cash flow
TWFG
TWFG
$40.3M more FCF
TWFG
$53.1M
$12.8M
VCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TWFG
TWFG
VCEL
VCEL
Revenue
$70.3M
$92.9M
Net Profit
$15.7M
$23.2M
Gross Margin
78.7%
Operating Margin
21.1%
24.1%
Net Margin
22.3%
25.0%
Revenue YoY
23.3%
Net Profit YoY
339.2%
17.3%
EPS (diluted)
$0.20
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TWFG
TWFG
VCEL
VCEL
Q4 25
$70.3M
$92.9M
Q3 25
$64.1M
$67.5M
Q2 25
$60.3M
$63.2M
Q1 25
$53.8M
$52.6M
Q4 24
$75.4M
Q3 24
$52.9M
$57.9M
Q2 24
$53.0M
$52.7M
Q1 24
$51.3M
Net Profit
TWFG
TWFG
VCEL
VCEL
Q4 25
$15.7M
$23.2M
Q3 25
$1.7M
$5.1M
Q2 25
$2.0M
$-553.0K
Q1 25
$1.3M
$-11.2M
Q4 24
$19.8M
Q3 24
$1.2M
$-901.0K
Q2 24
$0
$-4.7M
Q1 24
$-3.9M
Gross Margin
TWFG
TWFG
VCEL
VCEL
Q4 25
78.7%
Q3 25
73.5%
Q2 25
73.7%
Q1 25
69.0%
Q4 24
77.6%
Q3 24
71.9%
Q2 24
69.5%
Q1 24
68.9%
Operating Margin
TWFG
TWFG
VCEL
VCEL
Q4 25
21.1%
24.1%
Q3 25
14.1%
5.1%
Q2 25
12.2%
-3.2%
Q1 25
10.6%
-24.3%
Q4 24
24.5%
Q3 24
11.3%
-4.3%
Q2 24
14.2%
-11.5%
Q1 24
-10.7%
Net Margin
TWFG
TWFG
VCEL
VCEL
Q4 25
22.3%
25.0%
Q3 25
2.7%
7.5%
Q2 25
3.2%
-0.9%
Q1 25
2.5%
-21.4%
Q4 24
26.3%
Q3 24
2.2%
-1.6%
Q2 24
-8.9%
Q1 24
-7.5%
EPS (diluted)
TWFG
TWFG
VCEL
VCEL
Q4 25
$0.20
$0.46
Q3 25
$0.11
$0.10
Q2 25
$0.13
$-0.01
Q1 25
$0.09
$-0.23
Q4 24
$0.40
Q3 24
$0.08
$-0.02
Q2 24
$10.49
$-0.10
Q1 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TWFG
TWFG
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$155.9M
$137.5M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$83.4M
$354.6M
Total Assets
$372.3M
$488.0M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TWFG
TWFG
VCEL
VCEL
Q4 25
$155.9M
$137.5M
Q3 25
$151.0M
$135.4M
Q2 25
$159.8M
$116.9M
Q1 25
$196.4M
$112.9M
Q4 24
$116.2M
Q3 24
$191.2M
$101.7M
Q2 24
$25.8M
$102.5M
Q1 24
$110.6M
Total Debt
TWFG
TWFG
VCEL
VCEL
Q4 25
$2.0M
Q3 25
$5.8M
Q2 25
$6.4M
Q1 25
$7.0M
Q4 24
Q3 24
$7.8M
Q2 24
$49.6M
Q1 24
Stockholders' Equity
TWFG
TWFG
VCEL
VCEL
Q4 25
$83.4M
$354.6M
Q3 25
$79.4M
$321.9M
Q2 25
$78.7M
$306.8M
Q1 25
$75.2M
$295.5M
Q4 24
$292.0M
Q3 24
$71.1M
$257.5M
Q2 24
$243.0M
Q1 24
$233.9M
Total Assets
TWFG
TWFG
VCEL
VCEL
Q4 25
$372.3M
$488.0M
Q3 25
$349.2M
$453.3M
Q2 25
$342.8M
$435.6M
Q1 25
$330.5M
$424.6M
Q4 24
$432.7M
Q3 24
$313.1M
$390.4M
Q2 24
$157.2M
$376.8M
Q1 24
$356.7M
Debt / Equity
TWFG
TWFG
VCEL
VCEL
Q4 25
0.02×
Q3 25
0.07×
Q2 25
0.08×
Q1 25
0.09×
Q4 24
Q3 24
0.11×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TWFG
TWFG
VCEL
VCEL
Operating Cash FlowLast quarter
$53.5M
$15.0M
Free Cash FlowOCF − Capex
$53.1M
$12.8M
FCF MarginFCF / Revenue
75.6%
13.8%
Capex IntensityCapex / Revenue
0.5%
2.4%
Cash ConversionOCF / Net Profit
3.41×
0.65×
TTM Free Cash FlowTrailing 4 quarters
$93.2M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TWFG
TWFG
VCEL
VCEL
Q4 25
$53.5M
$15.0M
Q3 25
$15.0M
$22.1M
Q2 25
$9.6M
$8.2M
Q1 25
$15.6M
$6.6M
Q4 24
$22.2M
Q3 24
$11.7M
$10.2M
Q2 24
$17.2M
$18.5M
Q1 24
$7.2M
Free Cash Flow
TWFG
TWFG
VCEL
VCEL
Q4 25
$53.1M
$12.8M
Q3 25
$14.9M
$19.5M
Q2 25
$9.6M
$81.0K
Q1 25
$15.6M
$-7.6M
Q4 24
$8.5M
Q3 24
$11.5M
$-9.2M
Q2 24
$1.8M
Q1 24
$-6.8M
FCF Margin
TWFG
TWFG
VCEL
VCEL
Q4 25
75.6%
13.8%
Q3 25
23.2%
28.8%
Q2 25
15.9%
0.1%
Q1 25
29.0%
-14.5%
Q4 24
11.2%
Q3 24
21.7%
-15.9%
Q2 24
3.4%
Q1 24
-13.3%
Capex Intensity
TWFG
TWFG
VCEL
VCEL
Q4 25
0.5%
2.4%
Q3 25
0.1%
3.9%
Q2 25
0.1%
12.9%
Q1 25
0.0%
27.0%
Q4 24
18.3%
Q3 24
0.4%
33.5%
Q2 24
31.8%
Q1 24
27.3%
Cash Conversion
TWFG
TWFG
VCEL
VCEL
Q4 25
3.41×
0.65×
Q3 25
8.68×
4.35×
Q2 25
4.91×
Q1 25
11.69×
Q4 24
1.12×
Q3 24
10.16×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TWFG
TWFG

Agency$39.9M57%
TWFGMGA$18.4M26%
Contingent Income$7.3M10%
Fee Income$3.2M5%
Policy Fees$1.1M2%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons